Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
Sermorelin
Batch #
N/A
Formula
C149H246N44O42S
Mol Wt
3357.933 g/mol
CAS
86168-78-7
Latest
ISO 17025
8× Testing
99.7%
Purity
VariantSermorelin
COA ##13128
Labeled10mg
Validation KeyAXISBIOTECH
Tested05/12/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.7%
✓
Net Peptide Content - 10mg
✓
Identity (HPLC) - Sermorelin
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
The effect of sermorelin (GHRH 1-29) on GH secretion and body composition in adults
02
Growth-hormone-releasing factor: secretion and physiological significance
03
Safety and efficacy of sermorelin in adult patients with growth hormone deficiency
04
Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly
05
Half-life of endogenous GHRH in plasma
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
